Mendelian inheritance describes traits controlled by single genes that follow predictable patterns: one version (allele) can be dominant over another, and offspring receive one copy from each parent. Non-Mendelian inheritance is everything else, and it turns out to be the rule rather than the exception for most traits that matter in medicine and everyday life. The gap between these two frameworks has shaped modern genetics, from how doctors assess disease risk to how researchers engineer mosquitoes that can’t spread malaria.
What Mendelian Inheritance Actually Predicts
Gregor Mendel worked out his principles using pea plants in the 1860s, and the patterns he identified are real. A single gene controls a single trait. Each parent passes along one of two copies. One copy can mask the other. When you cross organisms and count offspring, the trait ratios come out clean and predictable. These principles hold beautifully for thousands of known conditions in humans: cystic fibrosis, sickle cell disease, Huntington’s disease, and many others where a mutation in one gene is both necessary and sufficient to cause the disorder.
The success of finding genes behind these single-gene (monogenic) disorders has been enormous. Researchers have mapped the mutations responsible for most known Mendelian conditions by combining family studies, genome sequencing, and statistical tools for tracking how traits move through pedigrees.1PubMed Central. The search for allelic variants that cause monogenic disorders or predispose to common, complex polygenic phenotypes But even Mendel’s own framework had limits he didn’t fully explore. Most natural variation in traits like behavior, height, or susceptibility to common diseases does not follow the neat dominant-recessive patterns his pea experiments revealed.2PubMed Central. Behavioral genetics and genomics: Mendel’s peas, mice, and bees
Dominance Is Not Always All-or-Nothing
Even within what looks like single-gene inheritance, dominance itself can be complicated. Mendel’s model assumes one allele completely masks the other, but plenty of single-gene traits show incomplete dominance, where the outcome lands somewhere between the two parental versions. A classic example is flower color in snapdragons: crossing a red-flowered plant with a white-flowered plant gives you pink offspring, not red. Both alleles contribute visibly to the outcome.
Then there’s codominance, where both alleles are fully expressed at the same time instead of blending. The ABO blood group system is the textbook case. The A and B alleles are codominant with each other (people with one of each have type AB blood), while both are dominant over O. The underlying gene itself turns out to be remarkably diverse, with dozens of known alleles, including variants that produce weaker versions of A or B by altering the activity of the enzyme the gene encodes.3PubMed Central. The ABO blood group gene: a locus of considerable genetic diversity
Dominance itself arises from multiple biological mechanisms, not just one. Sometimes a mutant protein actively interferes with the normal version, poisoning the molecular machinery even when a working copy is present. Other times, having just one working copy of a gene isn’t enough to produce the full amount of protein a cell needs, so a single faulty copy causes disease even though the other copy is fine. The unifying theme is that dominance reflects nonlinear relationships between what’s in your DNA and what shows up in your body.4PubMed Central. Mechanisms of Mendelian dominance These wrinkles still fit broadly under Mendel’s umbrella, but they show how much subtlety hides inside what sounds like a simple system.
Most Traits Are Polygenic
Height, blood pressure, body weight, risk of type 2 diabetes, susceptibility to depression: none of these follow a single-gene pattern. They are polygenic, shaped by contributions from many genes, each with a small effect. This is the single biggest departure from Mendelian genetics and the one that affects the most people.
The theoretical resolution came over a century ago, when the statistician Ronald Fisher showed that if you assume a large number of genetic variants, each nudging a trait by a tiny amount, you can explain why relatives resemble each other for quantitative traits without any single gene being decisive.5PubMed Central. Polygenic inheritance, GWAS, polygenic risk scores, and the search for functional variants Modern genome-wide studies have confirmed this picture: for most common conditions and traits, heritability is distributed across many genes of small effect rather than concentrated in one or two.6Nature Reviews Genetics. Common disorders are quantitative traits
For some conditions, both genes and environment matter in a way that creates a threshold effect. Common birth defects, for instance, tend to run in families without following any recognizable Mendelian ratio. They can be explained by a model in which everyone sits somewhere on a continuous scale of susceptibility (called “liability”) determined by both genetic and environmental factors; if your total liability crosses a certain threshold, you develop the condition.7PubMed. The multifactorial/threshold concept — uses and misuses This is fundamentally different from Mendel’s world, where you either have the allele or you don’t.
When Genes Talk to Each Other
Mendelian inheritance generally treats each gene as independent. In reality, genes interact. Epistasis is the term for when one gene’s effect depends on what’s happening at a different gene. Coat color in Labrador retrievers is a familiar example: one gene determines whether pigment is dark or light, but a second gene controls whether pigment is deposited in the fur at all. A dog can carry the “dark” version of the first gene and still be yellow if the second gene blocks pigment deposition. The interaction between the two genes produces outcomes that don’t match the ratios you’d predict from tracking either gene alone.8PubMed Central. Epistasis–the essential role of gene interactions in the structure and evolution of genetic systems
A related complication is pleiotropy, where a single gene influences multiple, seemingly unrelated traits. Thousands of genes in mammals affect traits across two or more organ systems.9PubMed Central. Pleiotropy data resource as a primer for investigating co-morbidities/multi-morbidities and their role in disease Both pleiotropy and epistasis are recognized as fundamental features of how quantitative traits are built.10Nature Reviews Genetics. Pleiotropy, epistasis and the genetic architecture of quantitative traits In a Mendelian world, one gene maps to one trait in a predictable way. In the real genome, genes are tangled in networks where changing one node can ripple across the whole system.
This is part of why the same genetic mutation can look so different from person to person. Three distinct phenomena contribute to this variability: incomplete penetrance (carrying the mutation but never developing the trait), variable expressivity (developing the trait but at different severities), and pleiotropy itself (the mutation affects more than one organ or function).11PubMed Central. Challenges in Clinicogenetic Correlations: One Gene – Many Phenotypes Families with the same mutation in the same gene can show a wide spectrum of outcomes, which looks nothing like the clean ratios Mendel observed in his pea garden.
Inheritance Outside the Nucleus
Mendel’s rules assume that all the important genes sit on chromosomes in the cell’s nucleus, inherited equally from both parents. Mitochondria break that assumption. These energy-producing structures inside your cells carry their own small genome, and you got essentially all of your mitochondrial DNA from your mother. Fathers almost never contribute.12PubMed Central. mtDNA Heteroplasmy: Origin, Detection, Significance, and Evolutionary Consequences
Mitochondrial inheritance creates patterns that don’t match any Mendelian prediction. An affected mother passes the trait to all her children. An affected father passes it to none. And because a single cell contains hundreds or thousands of mitochondria, a person can carry a mix of normal and mutant copies. Disease symptoms typically only appear when the proportion of mutant copies crosses a certain threshold, which varies by tissue and by individual.13PubMed Central. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches This threshold effect means that a mother with a mild form of a mitochondrial disease can have a child who is severely affected, or vice versa, depending on how the mitochondria were randomly distributed during early development. Genetic counselors find this one of the hardest inheritance patterns to predict.
Genes That Remember Which Parent They Came From
Mendelian inheritance doesn’t care whether an allele came from your mother or your father; the gene works the same way regardless of its parental origin. Genomic imprinting violates this assumption. Certain genes are chemically tagged so that only the copy from one specific parent is active, while the other is silenced.
The starkest illustration involves the same stretch of chromosome 15. If the paternally inherited copy of a particular set of genes in this region is missing or silenced, the result is Prader-Willi syndrome, a condition characterized by uncontrollable hunger and developmental delays.14PubMed Central. Prader-Willi Syndrome: Obesity due to Genomic Imprinting If the maternally inherited copy of a nearby gene in the same region is missing or silenced, the result is Angelman syndrome, a condition with severe intellectual disability and movement problems. Same chromosomal neighborhood, but which parent’s copy is affected determines an entirely different disease. The silencing is maintained by chemical modifications to DNA and the proteins it wraps around, a system that controls how the region’s genes are read without changing the DNA sequence itself.15PubMed Central. The imprinting mechanism of the Prader-Willi/Angelman regional control center
This parent-of-origin effect means two people can carry the exact same deletion and have completely different conditions depending on whether they inherited it from their mother or father. No Mendelian model accounts for that.
Mutations That Grow Over Generations
Mendel assumed DNA is passed along faithfully, with the same sequence in parent and child. Trinucleotide repeat expansions shatter that assumption. In several neurological disorders, a short DNA sequence is repeated in tandem, and the number of repeats can increase when the gene is passed from parent to child. More repeats mean earlier onset and greater severity. This is called anticipation, and it was considered a statistical artifact until researchers identified the molecular mechanism behind it.
Huntington’s disease, myotonic dystrophy, and fragile X syndrome all involve expanding repeats. A grandparent might carry a mildly expanded repeat and show no symptoms. Their child might have a longer expansion and develop symptoms in middle age. Their grandchild might carry an even longer expansion and be affected in childhood.16PubMed. Genetic anticipation. Expanding tandem repeats The gene is literally changing from one generation to the next, which means the mutation’s consequences aren’t fixed, they escalate. This is a radical departure from the stable transmission of DNA that Mendel’s framework assumed.
Mosaicism and Mutations That Happen After Conception
Mendelian genetics starts at fertilization: you get your genotype, and every cell in your body carries the same version. In practice, mutations accumulate throughout development as cells divide. By the time you’re an adult, different cells in your body carry slightly different genomes. Everyone is a genetic mosaic to some degree.17PubMed Central. Somatic Mosaicism: Implications for Disease and Transmission Genetics
Most of these post-conception mutations are harmless. But if one hits the right gene at the right time during development, it can cause disease in whatever tissues descended from that cell. A person with mosaicism might have a genetic disorder in one organ but not others, or might show a milder form of a condition that would be lethal if it were present in every cell. Importantly, if a mosaic mutation happens to land in cells that will become eggs or sperm, it can be passed to the next generation as a full constitutional mutation, seemingly appearing out of nowhere in a family with no history. This explains some cases where children develop severe genetic conditions despite neither parent carrying the mutation in their blood.
Cheating at Meiosis
Mendel’s first law says each parent has two copies of a gene and passes one to each offspring with a fifty-fifty chance. Meiotic drive systems break that rule by rigging the odds so that a particular chromosome gets transmitted to more than half of offspring.
The segregation distorter system in fruit flies is one of the best-studied examples. Males carrying it transmit the drive-bearing chromosome to nearly all their offspring instead of the expected half. The mechanism is ruthless: sperm that receive the competing chromosome develop abnormally and are functionally destroyed.18PubMed Central. On the components of segregation distortion in Drosophila melanogaster Research has shown that the damage occurs during the stage when sperm nuclei are being repackaged, and affected sperm end up with misshapen nuclei that get eliminated.19PLOS Genetics. Distinct spermiogenic phenotypes underlie sperm elimination in the Segregation Distorter meiotic drive system
Meiotic drive occurs across many species and in both sexes, though the specific mechanisms differ depending on whether meiosis produces one egg (asymmetric, as in females of most animals) or four equivalent products (symmetric, as in males).20PubMed Central. Mechanisms of meiotic drive in symmetric and asymmetric meiosis From an evolutionary perspective, these selfish genetic elements spread through populations even if they offer no benefit to the organism, because they have bypassed the fair lottery that Mendelian inheritance depends on.
Engineering Super-Mendelian Inheritance
Researchers have taken the concept of meiotic drive and built synthetic versions using CRISPR gene-editing technology. These engineered “gene drives” are designed to spread a chosen genetic modification through a population far faster than normal inheritance would allow. Under Mendelian rules, a new gene introduced into a population through one individual has a fifty-percent chance of being passed to each offspring. A gene drive pushes that well above fifty percent by copying itself onto the partner chromosome.
The approach has been demonstrated in disease-carrying mosquitoes. In Culex quinquefasciatus, the mosquito responsible for transmitting several tropical diseases, CRISPR-based gene drives showed biased inheritance at two separate gene locations, confirming that the copying mechanism works in this species.21Nature Communications. CRISPR-based gene drives generate super-Mendelian inheritance in the disease vector Culex quinquefasciatus Similar systems have been tested in Aedes aegypti, the yellow fever mosquito, though the underlying mechanism turned out to be more context-dependent than expected, with different molecular events driving inheritance bias depending on how and where the editing enzyme was expressed.22PubMed Central. A CRISPR endonuclease gene drive reveals distinct mechanisms of inheritance bias
Gene drives have even been demonstrated in mice, where restricting the editing enzyme to the female germline allowed the drive element to copy itself and increase its inheritance rate in the next generation.23Nature. Super-Mendelian inheritance mediated by CRISPR–Cas9 in the female mouse germline The potential applications range from suppressing mosquito populations that carry malaria to controlling invasive rodents on islands. The ethical and ecological questions are enormous, because once released, a gene drive that works as designed would be very difficult to recall.
What This Means for Medical Genetics
The practical consequence of non-Mendelian complexity is that predicting disease risk for common conditions is far harder than for single-gene disorders. For Mendelian diseases, a genetic test can give you a near-certain answer: you carry the mutation or you don’t. For polygenic conditions like heart disease, diabetes, or most cancers, researchers have developed polygenic risk scores that add up the tiny contributions of hundreds or thousands of genetic variants into a single number estimating your relative risk.
These scores are already entering clinical use in some settings. For breast cancer, a polygenic risk score combining information from hundreds of genetic variants has been integrated into clinical risk-assessment tools used at specialized centers in Europe.24PubMed Central. Clinical utility of polygenic risk scores: a critical appraisal But the scores are probabilistic, not deterministic. A high polygenic risk score for a condition does not mean you will develop it, and a low score does not mean you won’t. They shift the odds, much like a weather forecast shifts your expectations without promising anything. This is a fundamentally different kind of genetic information than learning you carry a BRCA1 mutation, and it requires a different kind of conversation between patients and their doctors.
The gap between Mendelian and non-Mendelian genetics also matters for how genetic test results are interpreted. A variant classified as “pathogenic” in a single-gene disorder still might not cause disease if the person also carries modifier genes that dampen its effect, or if the variant has incomplete penetrance. Meanwhile, the same condition might show up in someone whose genetic test comes back clean for known mutations, because the real cause is a mosaic mutation present in only some tissues, or an epigenetic change that no standard DNA test detects. Genetic testing has become spectacularly powerful, but the biology it’s trying to capture is messier than any single framework can handle.